{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T02:07:31Z","timestamp":1779070051785,"version":"3.51.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009827","name":"Alexandria University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009827","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Radiotherapy (RT) plays a key role in multidisciplinary treatment of Head and neck cancers (HNCs). Over the past two decades, advances have improved RT\u2019s tumor control and toxicity profiles. Precise delineation of gross tumor volume and organs at risk using CT and PET-CT is crucial for safe and effective RT. Additionally, RT increases the risk of thyroid dysfunction, especially hypothyroidism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>The present study compared PET-CT simulation and CT-alone planning in head and neck cancer (HNC) treatment, emphasizing their effects on thyroid gland function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The patients were divided into two groups according to the simulation method (PET-CT or CT), two fresh blood samples (5 mL\/ sample) were collected from each patient, before and after radiotherapy. TSH, FT3, and FT4 (Thyroid biomarkers) were assessed by electrochemiluminescent immunoassay (ECLIA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>PET-CT simulation demonstrated a significant improvement in GTVp delineation accuracy by 71.8% compared with CT. After radiotherapy, TSH levels show minor decline changes, whereas FT3 and FT4 levels declined significantly, with greater declines observed in stages II and III. The most common tumor site was the larynx (60% in PET-CT, 75% in CT), followed by the tongue, nasopharynx, and parotid gland.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PET-CT simulation offered superior GTVp delineation accuracy over CT, improving HNCs radiotherapy planning. Immediately after RT, radiotherapy caused significant declines in serum FT3 and FT4 levels, with only a minor, non-significant TSH declining, particularly in stage II\/III disease. Notably FT4 is little more affected in PET-CT simulation patient group, highlighting the need for thyroid function monitoring. These results advocate PET-CT integration in planning and routine endocrine monitoring for treatment complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13014-026-02840-x","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T02:04:58Z","timestamp":1779069898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative study between PET-CT simulation and CT for head and neck cancer treatment and their potential effect on the thyroid gland: a prospective comparative study"],"prefix":"10.1186","volume":"21","author":[{"given":"Sameh Fawzy","family":"Nakhla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youssef Abobker","family":"Abokasem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazem","family":"Elmansy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek Mohamed","family":"Salem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Fakhry","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebtsam Rizq","family":"Zaher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Ibrahim","family":"Morsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"2840_CR1","doi-asserted-by":"crossref","unstructured":"Xiong W, Li Z, Zeng X, Cui J, Cheng Z, Yang X, et al. The polymorphisms of ANXA6 influence head and neck cancer susceptibility in the Chinese Han population. Front Oncol. 2023;13.","DOI":"10.3389\/fonc.2023.1100781"},{"key":"2840_CR2","doi-asserted-by":"publisher","first-page":"106302","DOI":"10.1016\/j.archoralbio.2025.106302","volume":"176","author":"H-J Kim","year":"2025","unstructured":"Kim H-J, Park D-G, Choi S-J, Cho S-D. PCSK9 is a passenger gene in head and neck cancer with minimal pathological influence. Arch Oral Biol. 2025;176:106302.","journal-title":"Arch Oral Biol"},{"issue":"19","key":"2840_CR3","doi-asserted-by":"publisher","first-page":"e38614","DOI":"10.1016\/j.heliyon.2024.e38614","volume":"10","author":"SK Kavak","year":"2024","unstructured":"Kavak SK, Kavak EE. Dropped head syndrome secondary to head and neck cancer: Impact on funct\u0131onal and body image scale. Heliyon. 2024;10(19):e38614.","journal-title":"Heliyon"},{"key":"2840_CR4","doi-asserted-by":"crossref","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","DOI":"10.3322\/caac.21660"},{"issue":"1","key":"2840_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1017\/S002221512200055X","volume":"137","author":"K Panara","year":"2022","unstructured":"Panara K, Go B, Shah M, Majmudar T, Barrette LX, Moreira AG, et al. Clinical practice guidelines on nutrition management in head and neck cancer: a systematic quality appraisal using the Appraisal of Guidelines for Research and Evaluation 2nd edition instrument. J Laryngology Otology. 2022;137(1):37\u201343.","journal-title":"J Laryngology Otology"},{"key":"2840_CR6","doi-asserted-by":"crossref","unstructured":"Cooper Jay S, Pajak Thomas F, Forastiere Arlene A, Jacobs J, Campbell Bruce H, Saxman Scott B, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 350(19):1937\u201344.","DOI":"10.1056\/NEJMoa032646"},{"issue":"1","key":"2840_CR7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.radonc.2007.04.002","volume":"85","author":"R Corv\u00f2","year":"2007","unstructured":"Corv\u00f2 R. Evidence-based radiation oncology in head and neck squamous cell carcinoma. Radiother Oncol. 2007;85(1):156\u201370.","journal-title":"Radiother Oncol"},{"issue":"1","key":"2840_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/ssu.1018","volume":"20","author":"V Rudat","year":"2001","unstructured":"Rudat V, Wannenmacher M. Role of multimodal treatment in oropharynx, larynx, and hypopharynx cancer. Semin Surg Oncol. 2001;20(1):66\u201374.","journal-title":"Semin Surg Oncol"},{"issue":"1","key":"2840_CR9","first-page":"391917","volume":"2012","author":"V Rudat","year":"2012","unstructured":"Rudat V, Ahmet-Osman S, Schramm O, Dietz A. Definitive Radiotherapy versus Postoperative Radiotherapy of Patients with Oro- and Hypopharyngeal Cancer: Impact of Prognostic Factors. J Oncol. 2012;2012(1):391917.","journal-title":"J Oncol"},{"key":"2840_CR10","doi-asserted-by":"crossref","unstructured":"Ko HC, Cosper PF, Kimple RJ, Witek ME. Chapter 3 - Combining radiation and chemotherapy to improve the therapeutic ratio. In: Kimple RJ, editor. Improving the Therapeutic Ratio in Head and Neck Cancer. Academic. 2020;6:49\u201363.","DOI":"10.1016\/B978-0-12-817868-3.00003-2"},{"issue":"7","key":"2840_CR11","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.7150\/jca.71526","volume":"13","author":"Z Lu","year":"2022","unstructured":"Lu Z, Zhou Y, Jing Q. Wnt5a-mediated autophagy promotes radiation resistance of nasopharyngeal carcinoma. J Cancer. 2022;13(7):2388\u201396.","journal-title":"J Cancer"},{"issue":"6","key":"2840_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1159\/000477128","volume":"40","author":"R Semrau","year":"2017","unstructured":"Semrau R. The Role of Radiotherapy in the Definitive and Postoperative Treatment of Advanced Head and Neck Cancer. Oncol Res Treat. 2017;40(6):347\u201352.","journal-title":"Oncol Res Treat"},{"issue":"2","key":"2840_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4103\/0971-6203.94739","volume":"37","author":"AS Pradhan","year":"2012","unstructured":"Pradhan AS, Kim JL, Lee JI. On the use of effective dose (E) in medical exposures. J Med Phys. 2012;37(2):63\u20135.","journal-title":"J Med Phys"},{"key":"2840_CR14","doi-asserted-by":"publisher","first-page":"111892","DOI":"10.1016\/j.apradiso.2025.111892","volume":"224","author":"P Sheikhzadeh","year":"2025","unstructured":"Sheikhzadeh P, Asami M, Mofrad MS, Abdolmaleki M, Mohammadi T, Kasraie N. Organ doses, effective dose, and cancer risk estimation from whole-body CT scans in PET-CT imaging. Appl Radiat Isot. 2025;224:111892.","journal-title":"Appl Radiat Isot"},{"key":"2840_CR15","unstructured":"Khan FM, Gibbons JP. Khan\u2019s the physics of radiation therapy. Lippincott Williams & Wilkins; 2014."},{"key":"2840_CR16","volume-title":"Radiation oncology physics a handbook for teachers and students","author":"EIAEA Podgorsak","year":"2005","unstructured":"Podgorsak EIAEA. Radiation oncology physics a handbook for teachers and students. Vienna: International Atomic Energy Agency; 2005."},{"key":"2840_CR17","doi-asserted-by":"crossref","unstructured":"Ferrando O, Scolaro T, Ciarmiello A, Foppiano F. Target volume definition and dosimetric issues in radiotherapy treatment of head and neck disease with FDG-PET\/CT: A monocentric experience. J Diagn Imaging Therapy. 2018:14\u20139.","DOI":"10.17229\/jdit.2018-0223-031"},{"issue":"9","key":"2840_CR18","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.oraloncology.2006.10.011","volume":"43","author":"J-L Roh","year":"2007","unstructured":"Roh J-L, Yeo N-K, Kim JS, Lee JH, Cho K-J, Choi S-H, et al. Utility of 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography and positron emission tomography\/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Oral Oncol. 2007;43(9):887\u201393.","journal-title":"Oral Oncol"},{"issue":"9","key":"2840_CR19","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.2967\/jnumed.108.051649","volume":"49","author":"C-H Baek","year":"2008","unstructured":"Baek C-H, Chung MK, Son Y-I, Choi JY, Kim H-J, Yim YJ, et al. Tumor Volume Assessment by < sup>18 F-FDG PET\/CT in Patients with Oral Cavity Cancer with Dental Artifacts on CT or MR Images. J Nucl Med. 2008;49(9):1422\u20138.","journal-title":"J Nucl Med"},{"key":"2840_CR20","unstructured":"Mak D, Corry J, Lau E, Rischin D, Hicks R. Role of FDG-PET\/CT in staging and follow-up of head and neck squamous cell carcinoma. Q J Nucl Med Mol Imaging. 2011;55(5):487\u201399."},{"issue":"11","key":"2840_CR21","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1002\/hed.20629","volume":"29","author":"A Connell","year":"2007","unstructured":"Connell A, Corry C, Milner J, Hogg AD, Hicks A, Rischin RJ. Clinical impact of, and prognostic stratification by, F-18 FDG PET\/CT in head and neck mucosal squamous cell carcinoma. Head Neck. 2007;29(11):986\u201395.","journal-title":"Head Neck"},{"issue":"1 suppl","key":"2840_CR22","first-page":"S78","volume":"48","author":"J Czernin","year":"2007","unstructured":"Czernin J, Allen-Auerbach M, Schelbert HR. Improvements in cancer staging with PET\/CT: literature-based evidence as of September 2006. J Nucl Med. 2007;48(1 suppl):S78\u201388.","journal-title":"J Nucl Med"},{"issue":"5","key":"2840_CR23","doi-asserted-by":"publisher","first-page":"429","DOI":"10.7785\/tcrt.2012.500342","volume":"12","author":"P Metcalfe","year":"2013","unstructured":"Metcalfe P, Liney GP, Holloway L, Walker A, Barton M, Delaney GP, et al. The Potential for an Enhanced Role for MRI in Radiation-Therapy Treatment Planning. Technol Cancer Res Treat. 2013;12(5):429\u201346.","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"2840_CR24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13014-018-1091-1","volume":"13","author":"PR Roberts","year":"2018","unstructured":"Roberts PR, Jani AB, Packianathan S, Albert A, Bhandari R, Vijayakumar S. Upcoming imaging concepts and their impact on treatment planning and treatment response in radiation oncology. Radiat Oncol. 2018;13(1):146.","journal-title":"Radiat Oncol"},{"issue":"3","key":"2840_CR25","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.radonc.2011.07.025","volume":"101","author":"G Delouya","year":"2011","unstructured":"Delouya G, Igidbashian L, Houle A, B\u00e9lair M, Boucher L, Cohade C, et al. 18F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer. Radiother Oncol. 2011;101(3):362\u20138.","journal-title":"Radiother Oncol"},{"issue":"3","key":"2840_CR26","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.ijrobp.2008.04.059","volume":"73","author":"A Guido","year":"2009","unstructured":"Guido A, Fuccio L, Rombi B, Castellucci P, Cecconi A, Bunkheila F, et al. Combined < sup>18F-FDG-PET\/CT Imaging in Radiotherapy Target Delineation for Head-and-Neck Cancer. Int J Radiat Oncol Biol Phys. 2009;73(3):759\u201363.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2840_CR27","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.radonc.2011.07.025","volume":"101","author":"G Delouya","year":"2011","unstructured":"Delouya G, Igidbashian L, Houle A, Belair M, Boucher L, Cohade C, et al. (1)(8)F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer. Radiother Oncol. 2011;101(3):362\u20138.","journal-title":"Radiother Oncol"},{"issue":"5","key":"2840_CR28","first-page":"521","volume":"55","author":"AI Arens","year":"2011","unstructured":"Arens AI, Troost EG, Schinagl D, Kaanders JH, Oyen WJ. FDG-PET\/CT in radiation treatment planning of head and neck squamous cell carcinoma. Q J Nucl Med Mol Imaging. 2011;55(5):521\u20138.","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"3","key":"2840_CR29","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2967\/jnumed.110.075689","volume":"52","author":"V Gr\u00e9goire","year":"2011","unstructured":"Gr\u00e9goire V, Chiti A. Molecular Imaging in Radiotherapy Planning for Head and Neck Tumors: FIGURE 1. J Nucl Med. 2011;52(3):331\u20134.","journal-title":"J Nucl Med"},{"issue":"8","key":"2840_CR30","first-page":"4220","volume":"30","author":"NE Nawar","year":"2024","unstructured":"Nawar NE, AL-Hosainy AM, Amin SA, Mandour DA. Radiotherapy Induced Thyroid Gland Dysfunction Among Patients With Head and Neck Cancers. Zagazig Univ Med J. 2024;30(8):4220\u201339.","journal-title":"Zagazig Univ Med J"},{"issue":"1","key":"2840_CR31","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s12070-018-1347-y","volume":"71","author":"D Rao","year":"2019","unstructured":"Rao D, Shah S. Thyroid Dysfunction Following Management of Non-thyroid Head and Neck Cancers. Indian J Otolaryngol Head Neck Surg. 2019;71(1):447\u201352.","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"issue":"2","key":"2840_CR32","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.radonc.2004.03.004","volume":"71","author":"VWC Wu","year":"2004","unstructured":"Wu VWC, Kwong DLW, Sham JST. Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy. Radiother Oncol. 2004;71(2):201\u20136.","journal-title":"Radiother Oncol"},{"key":"2840_CR33","doi-asserted-by":"crossref","unstructured":"Rooney MK, Andring LM, Corrigan KL, Bernard V, Williamson TD, Fuller CD, et al. Hypothyroidism following radiotherapy for head and neck cancer: a systematic review of the literature and opportunities to improve the therapeutic ratio. Cancers (Basel). 2023;15(17).","DOI":"10.3390\/cancers15174321"},{"issue":"null","key":"2840_CR34","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2147\/TCRM.S70652","volume":"11","author":"R Pinna","year":"2015","unstructured":"Pinna R, Campus G, Cumbo E, Mura I, Milia E. Xerostomia induced by radiotherapy: an overview of the physiopathology, clinical evidence, and management of the oral damage. Ther Clin Risk Manag. 2015;11(null):171\u201388.","journal-title":"Ther Clin Risk Manag"},{"issue":"3","key":"2840_CR35","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/jrr\/rrv006","volume":"56","author":"M Fujiwara","year":"2015","unstructured":"Fujiwara M, Kamikonya N, Odawara S, Suzuki H, Niwa Y, Takada Y, et al. The threshold of hypothyroidism after radiation therapy for head and neck cancer: a retrospective analysis of 116 cases. J Radiat Res. 2015;56(3):577\u201382.","journal-title":"J Radiat Res"},{"key":"2840_CR36","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fonc.2012.00189","volume":"2","author":"K Newbold","year":"2012","unstructured":"Newbold K, Powell C. PET\/CT in Radiotherapy Planning for Head and Neck Cancer. Front Oncol. 2012;2:189.","journal-title":"Front Oncol"},{"key":"2840_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ctro.2022.01.001","volume":"33","author":"JC Chow","year":"2022","unstructured":"Chow JC, Cheung K-M, Cheung GT, Tam AH, Lui JC, Lee FK, et al. Dose-volume predictors of post-radiation primary hypothyroidism in head and neck cancer: A systematic review. Clin Translational Radiation Oncol. 2022;33:83\u201392.","journal-title":"Clin Translational Radiation Oncol"},{"key":"2840_CR38","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.radonc.2019.07.025","volume":"142","author":"S n den Bosch","year":"2020","unstructured":"van den Bosch S, Doornaert PA, Dijkema T, Zwijnenburg EM, Verhoef LC, Hoeben BA, et al. 18F-FDG-PET\/CT-based treatment planning for definitive (chemo) radiotherapy in patients with head and neck squamous cell carcinoma improves regional control and survival. Radiother Oncol. 2020;142:107\u201314.","journal-title":"Radiother Oncol"},{"issue":"1","key":"2840_CR39","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1021\/pr800545q","volume":"8","author":"MK Tuck","year":"2009","unstructured":"Tuck MK, Chan DW, Chia D, Godwin AK, Grizzle WE, Krueger KE, et al. Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. J Proteome Res. 2009;8(1):113\u20137.","journal-title":"J Proteome Res"},{"issue":"9","key":"2840_CR40","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1007\/s00066-019-01480-3","volume":"195","author":"N Samo\u0142yk-Kogaczewska","year":"2019","unstructured":"Samo\u0142yk-Kogaczewska N, Sierko E, Zuzda K, Gugnacki P, Szumowski P, Mojsak M, et al. PET\/MRI-guided GTV delineation during radiotherapy planning in patients with squamous cell carcinoma of the tongue. Strahlenther Onkol. 2019;195(9):780\u201391.","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"2840_CR41","first-page":"1","volume":"39","author":"A Hussein","year":"2018","unstructured":"Hussein A, Zehra O, Kohel H, Elsaid A. Comparing between radiotherapy planning using positron, emission tomography-computed tomography (PET-CT) and computed tomography (CT) in head and neck. J Med Res Inst. 2018;39(1):1\u20135.","journal-title":"J Med Res Inst"},{"issue":"4","key":"2840_CR42","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jcms.2013.09.009","volume":"42","author":"L Bern\u00e1t","year":"2014","unstructured":"Bern\u00e1t L, Hru\u0161\u00e1k D. Hypothyroidism after radiotherapy of head and neck cancer. J Cranio-Maxillofacial Surg. 2014;42(4):356\u201361.","journal-title":"J Cranio-Maxillofacial Surg"},{"issue":"1","key":"2840_CR43","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ijrobp.2011.05.064","volume":"83","author":"M Bakhshandeh","year":"2012","unstructured":"Bakhshandeh M, Hashemi B, Mahdavi SR, Nikoofar A, Edraki HR, Kazemnejad A. Evaluation of thyroid disorders during head-and-neck radiotherapy by using functional analysis and ultrasonography. Int J Radiation Oncology* Biology* Phys. 2012;83(1):198\u2013203.","journal-title":"Int J Radiation Oncology* Biology* Phys"},{"key":"2840_CR44","doi-asserted-by":"crossref","unstructured":"Venkada MG, Rawat S, Choudhury PS, Rajesh T, Rao SA, Khullar P, et al. A quantitative comparison of gross tumour volumes delineated on [18F]-FDG PET-CT scan and CECT scan in head and neck cancers. Indian J Nuclear Med. 2012;27(2).","DOI":"10.4103\/0972-3919.110691"},{"issue":"3","key":"2840_CR45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.21608\/jcbr.2022.138778.1259","volume":"6","author":"S Nakhla","year":"2022","unstructured":"Nakhla S, Morsi M, Fadel S, Al-adawi M. Evaluation of radiation-induced thyroid disorders in non-thyroid head and neck cancers in childhood. Egypt J Cancer Biomedical Res. 2022;6(3):11\u20138.","journal-title":"Egypt J Cancer Biomedical Res"},{"issue":"18","key":"2840_CR46","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.3390\/cancers16183140","volume":"16","author":"O Hamidi","year":"2024","unstructured":"Hamidi O, Miljanic M, Tumyan G, Christie A, Mirfakhraee S, Ali S, et al. Adrenal insufficiency following stereotactic ablative radiotherapy (SAbR) of adrenal gland metastases. Cancers. 2024;16(18):3140.","journal-title":"Cancers"},{"issue":"1","key":"2840_CR47","doi-asserted-by":"publisher","first-page":"100801","DOI":"10.1016\/j.adro.2021.100801","volume":"7","author":"L Hilal","year":"2022","unstructured":"Hilal L, Cercek A, Navilio J, Hsu M, Zhang Z, Brady P, et al. Factors Associated With Premature Ovarian Insufficiency in Young Women With Locally Advanced Rectal Cancer Treated With Pelvic Radiation Therapy. Adv radiation Oncol. 2022;7(1):100801.","journal-title":"Adv radiation Oncol"},{"issue":"3","key":"2840_CR48","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0167-8140(03)00120-8","volume":"68","author":"S Dueland","year":"2003","unstructured":"Dueland S, Guren MG, Olsen DR, Poulsen JP, Tveit KM. Radiation therapy induced changes in male sex hormone levels in rectal cancer patients. Radiother Oncol. 2003;68(3):249\u201353.","journal-title":"Radiother Oncol"},{"key":"2840_CR49","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.radonc.2020.07.009","volume":"151","author":"P Polanowski","year":"2020","unstructured":"Polanowski P, Wydma\u0144ski J, Tukiendorf A, Sk\u0142adowski K. The analysis of absorbed dose by pancreas during gastric cancer radiotherapy. Radiother Oncol. 2020;151:20\u20133.","journal-title":"Radiother Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-026-02840-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-026-02840-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-026-02840-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T02:05:02Z","timestamp":1779069902000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13014-026-02840-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2840"],"URL":"https:\/\/doi.org\/10.1186\/s13014-026-02840-x","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"21 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study adhered to the Declaration of Helsinki\u2019s ethical principles, with approval from the Medical Research Institute\u2019s Ethics Committee (IOROH: lORG 0008812). Participants were informed about study objectives, procedures, risks, and benefits, and consent was obtained. Data confidentiality and anonymity were maintained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"76"}}